These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35386230)

  • 21. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
    He J; Zeng C; Long Y
    Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repo-man at the intersection of chromatin remodelling, DNA repair, nuclear envelope organization, and cancer progression.
    Vagnarelli P
    Adv Exp Med Biol; 2014; 773():401-14. PubMed ID: 24563358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
    Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
    Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
    Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
    Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
    Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
    Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
    J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-DONSON promotes malignant progression of glioma through modulating FOXO3.
    Zou Z; Dong YS; Liu JM; Zhao ZH; Li G; Liu DD
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):749-757. PubMed ID: 32016978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
    Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
    Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
    Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
    J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
    Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
    Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-182 as a prognostic marker for glioma progression and patient survival.
    Jiang L; Mao P; Song L; Wu J; Huang J; Lin C; Yuan J; Qu L; Cheng SY; Li J
    Am J Pathol; 2010 Jul; 177(1):29-38. PubMed ID: 20472885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
    J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients.
    Wu Z; Wang Q; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Tu Y
    J Neurol Sci; 2013 Dec; 335(1-2):191-6. PubMed ID: 24139839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profile and prognostic values of Chromobox family members in human glioblastoma.
    Li J; Xu Z; Zhou L; Hu K
    Aging (Albany NY); 2022 Feb; 14(4):1910-1931. PubMed ID: 35210369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.